Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Phase 3 trial assessing BF-200 ALA (Ameluz) with photodynamic therapy for actinic keratosis on extremities and neck/trunk; results completed…
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Phase 3 trial evaluating BF-200 ALA (Ameluz) with photodynamic therapy for actinic keratosis on extremities and neck/trunk; study completed …
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Phase 3 trial evaluating BF-200 ALA (Ameluz) with photodynamic therapy for actinic keratosis on extremities and neck/trunk completed.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of tirbanibulin ointment for actinic keratosis in adults completed.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities [Phase 3]
A Phase 3 clinical trial evaluating reformulated Levulan Kerastick Plus PDT for actinic keratosis on the upper extremities is currently recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy [NA]
A completed clinical trial evaluating the FLEXITHERALIGHT device versus conventional photodynamic therapy for actinic keratosis.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses [Phase 3]
A Phase 3 pilot clinical trial is evaluating topical fluorouracil alone versus fluorouracil combined with calcipotriene for actinic keratosi…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis [Phase 3]
Phase 3 study evaluating the efficacy and safety of tirbanibulin ointment in adults with actinic keratosis has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses [Phase 2]
Phase 2 clinical trial completed evaluating imaging methods to monitor photosensitizer distribution and tissue oxygenation during photodynam…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Trial to Investigate GZ21T in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating GZ21T in healthy volunteers has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage [Phase 1]
This update reports the completion of a Phase 1 study evaluating Ameluz in combination with the BBL HEROic device for actinic keratosis and …
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK [NA]
Completed trial comparing 1-hour versus 2-hour illumination in indoor daylight photodynamic therapy for scalp actinic keratosis to evaluate …
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses [Phase 2]
A Phase 2 trial evaluated short contact protocols to reduce pain during red-light photodynamic therapy with 10% ALA gel for actinic keratosi…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Comparison of Nicotinamide Treatments for Actinic Keratosis [Phase 1]
A Phase 1 clinical trial comparing nicotinamide treatments for actinic keratosis has completed. The study was sponsored by the Federal Unive…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis [Phase 2]
Phase 2 study evaluating the safety and efficacy of Bimiralisib Gel in actinic keratosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer [Phase 3]
Phase 3 trial evaluating Photodynamic Therapy with Metvix cream in organ transplant recipients with non-melanoma skin cancers completed; res…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: OCT and Invasion in Cutaneous Skin Lesions
A completed clinical trial from Maastricht University Medical Center evaluating OCT imaging and invasion in cutaneous skin lesions. The stud…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp [Phase 4]
Phase 4 trial comparing ingenol mebutate gel 0.015% with diclofenac sodium gel 3% for actinic keratoses on the face or scalp, evaluating eff…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of different concentrations of an ingenol derivative topical therapy for actinic kera…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Biological Effects of LEO 43204 in Actinic Keratosis [Phase 1]
This Phase 1 trial evaluated the biological effects of the topical agent LEO 43204 in actinic keratosis and has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel [Phase 1]
Phase 1 study evaluating the sensitizing potential of LEO 43204 Gel in actinic keratosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% [Phase 1]
This Phase 1 trial of Ingenol Mebutate Gel 0.05% for actinic keratosis reports histological confirmation of clinical clearance after treatme…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology [Phase 1]
Phase 1 trial update showing biological effects of PEP005 Gel in actinic keratosis as assessed by histology; study completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions [Phase 1]
Phase 1 pharmacokinetic study evaluating Ingenol Mebutate Gel in actinic keratosis under maximum use conditions.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions [Phase 1]
A Phase 1 pharmacokinetic study of LEO 43204 Gel in actinic keratosis under maximal-use conditions has completed, reporting PK data.